{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:42:30Z","timestamp":1793148150493,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32271193"],"award-info":[{"award-number":["32271193"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-025-08854-7","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:12:42Z","timestamp":1760026362000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["HSPA4 restrains transferrin in dopaminergic neurons to attenuate ferroptosis in a Parkinson\u2019s disease model"],"prefix":"10.1038","volume":"8","author":[{"given":"Tong","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanhuan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuhong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8411-4619","authenticated-orcid":false,"given":"Cheng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4068-8631","authenticated-orcid":false,"given":"Lihua","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"key":"8854_CR1","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","volume":"18","author":"GBDN Collaborators","year":"2019","unstructured":"Collaborators, G. B. D. N. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 18, 459\u2013480 (2019).","journal-title":"Lancet Neurol."},{"key":"8854_CR2","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia, L. V. & Lang, A. E. Parkinson's disease. Lancet 386, 896\u2013912 (2015).","journal-title":"Lancet"},{"key":"8854_CR3","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.amjmed.2019.03.001","volume":"132","author":"MT Hayes","year":"2019","unstructured":"Hayes, M. T. Parkinson's disease and Parkinsonism. Am. J. Med. 132, 802\u2013807 (2019).","journal-title":"Am. J. Med."},{"key":"8854_CR4","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem, B. R., Okun, M. S. & Klein, C. Parkinson's disease. Lancet 397, 2284\u20132303 (2021).","journal-title":"Lancet"},{"key":"8854_CR5","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S1474-4422(21)00061-2","volume":"20","author":"N Vijiaratnam","year":"2021","unstructured":"Vijiaratnam, N., Simuni, T., Bandmann, O., Morris, H. R. & Foltynie, T. Progress towards therapies for disease modification in Parkinson's disease. Lancet Neurol. 20, 559\u2013572 (2021).","journal-title":"Lancet Neurol."},{"key":"8854_CR6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.lfs.2019.03.057","volume":"226","author":"C Raza","year":"2019","unstructured":"Raza, C., Anjum, R. & Shakeel, N. U. Parkinson's disease: mechanisms, translational models and management strategies. Life Sci. 226, 77\u201390 (2019).","journal-title":"Life Sci."},{"key":"8854_CR7","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/nature10317","volume":"475","author":"FU Hartl","year":"2011","unstructured":"Hartl, F. U., Bracher, A. & Hayer-Hartl, M. Molecular chaperones in protein folding and proteostasis. Nature 475, 324\u2013332 (2011).","journal-title":"Nature"},{"key":"8854_CR8","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1007\/s10787-025-01672-7","volume":"33","author":"A Awasthi","year":"2025","unstructured":"Awasthi, A., Maparu, K. & Singh, S. Ferroptosis role in complexity of cell death: unrevealing mechanisms in Parkinson's disease and therapeutic approaches. Inflammopharmacology 33, 1271\u20131287 (2025).","journal-title":"Inflammopharmacology"},{"key":"8854_CR9","doi-asserted-by":"publisher","first-page":"101890","DOI":"10.1016\/j.pneurobio.2020.101890","volume":"196","author":"L Mahoney-S\u00e1nchez","year":"2021","unstructured":"Mahoney-S\u00e1nchez, L. et al. Ferroptosis and its potential role in the physiopathology of Parkinson's Disease. Prog. Neurobiol. 196, 101890 (2021).","journal-title":"Prog. Neurobiol."},{"key":"8854_CR10","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1038\/s41418-021-00814-y","volume":"28","author":"D Moujalled","year":"2021","unstructured":"Moujalled, D., Strasser, A. & Liddell, J. R. Molecular mechanisms of cell death in neurological diseases. Cell Death Differ. 28, 2029\u20132044 (2021).","journal-title":"Cell Death Differ."},{"key":"8854_CR11","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1158\/0008-5472.CAN-16-1979","volume":"77","author":"S Zhu","year":"2017","unstructured":"Zhu, S. et al. HSPA5 regulates ferroptotic cell death in cancer cells. Cancer Res. 77, 2064\u20132077 (2017).","journal-title":"Cancer Res."},{"key":"8854_CR12","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1186\/s13046-019-1413-7","volume":"38","author":"YB Chen","year":"2019","unstructured":"Chen, Y. B. et al. Dihydroartemisinin-induced unfolded protein response feedback attenuates ferroptosis via PERK\/ATF4\/HSPA5 pathway in glioma cells. J. Exp. Clin. Cancer Res. 38, 402 (2019).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"8854_CR13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.molimm.2023.05.001","volume":"158","author":"J Li","year":"2023","unstructured":"Li, J. et al. HSPA5, as a ferroptosis regulator, may serve as a potential therapeutic for head and neck squamous cell carcinoma. Mol. Immunol. 158, 79\u201390 (2023).","journal-title":"Mol. Immunol."},{"key":"8854_CR14","doi-asserted-by":"publisher","first-page":"5144","DOI":"10.3390\/ijms24065144","volume":"24","author":"QH Wang","year":"2023","unstructured":"Wang, Q. H. et al. HSPA5 promotes the proliferation, metastasis and regulates ferroptosis of bladder cancer. Int J. Mol. Sci. 24, 5144 (2023).","journal-title":"Int J. Mol. Sci."},{"key":"8854_CR15","doi-asserted-by":"publisher","first-page":"614888","DOI":"10.3389\/fgene.2020.614888","volume":"11","author":"X Du","year":"2020","unstructured":"Du, X. & Zhang, Y. Integrated analysis of immunity- and ferroptosis-related biomarker signatures to improve the prognosis prediction of hepatocellular carcinoma. Front. Genet. 11, 614888 (2020).","journal-title":"Front. Genet."},{"key":"8854_CR16","doi-asserted-by":"publisher","first-page":"e14812","DOI":"10.1111\/exd.14812","volume":"33","author":"XM Hu","year":"2024","unstructured":"Hu, X. M. et al. Pyroptosis-related gene signature elicits immune response in rosacea. Exp. Dermatol. 33, e14812 (2024).","journal-title":"Exp. Dermatol."},{"key":"8854_CR17","doi-asserted-by":"publisher","first-page":"e97880","DOI":"10.1371\/journal.pone.0097880","volume":"9","author":"LW Hu","year":"2014","unstructured":"Hu, L. W., Yen, J. H., Shen, Y. T., Wu, K. Y. & Wu, M. J. Luteolin modulates 6-hydroxydopamine-induced transcriptional changes of stress response pathways in PC12 cells. PLoS One 9, e97880 (2014).","journal-title":"PLoS One"},{"key":"8854_CR18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s12264-015-0001-x","volume":"32","author":"K Tao","year":"2016","unstructured":"Tao, K. et al. Salidroside protects against 6-hydroxydopamine-induced cytotoxicity by attenuating ER stress. Neurosci. Bull. 32, 61\u201369 (2016).","journal-title":"Neurosci. Bull."},{"key":"8854_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12929-015-0146-y","volume":"22","author":"YL Lin","year":"2015","unstructured":"Lin, Y. L., Tsay, H. J., Lai, T. H., Tzeng, T. T. & Shiao, Y. J. Lithospermic acid attenuates 1-methyl-4-phenylpyridine-induced neurotoxicity by blocking neuronal apoptotic and neuroinflammatory pathways. J. Biomed. Sci. 22, 37 (2015).","journal-title":"J. Biomed. Sci."},{"key":"8854_CR20","doi-asserted-by":"publisher","first-page":"467","DOI":"10.4103\/1673-5374.153698","volume":"10","author":"HF Li","year":"2015","unstructured":"Li, H. F., Zhao, S. X., Xing, B. P. & Sun, M. L. Ulinastatin suppresses endoplasmic reticulum stress and apoptosis in the hippocampus of rats with acute paraquat poisoning. Neural Regen. Res. 10, 467\u2013472 (2015).","journal-title":"Neural Regen. Res."},{"key":"8854_CR21","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.toxlet.2009.08.024","volume":"191","author":"W Yang","year":"2009","unstructured":"Yang, W., Tiffany-Castiglioni, E., Koh, H. C. & Son, I. H. Paraquat activates the IRE1\/ASK1\/JNK cascade associated with apoptosis in human neuroblastoma SH-SY5Y cells. Toxicol. Lett. 191, 203\u2013210 (2009).","journal-title":"Toxicol. Lett."},{"key":"8854_CR22","doi-asserted-by":"publisher","first-page":"3951","DOI":"10.3390\/ijms25073951","volume":"25","author":"MB Pazi","year":"2024","unstructured":"Pazi, M. B., Belan, D. V. & Komarova, E. Y. Ekimova IV. Intranasal administration of GRP78 protein (HSPA5) confers neuroprotection in a lactacystin-induced rat model of Parkinson's Disease. Int J. Mol. Sci. 25, 3951 (2024).","journal-title":"Int J. Mol. Sci."},{"key":"8854_CR23","doi-asserted-by":"publisher","first-page":"166365","DOI":"10.1016\/j.bbadis.2022.166365","volume":"1868","author":"YN Yang","year":"2022","unstructured":"Yang, Y. N. et al. SIRT1 attenuates neuroinflammation by deacetylating HSPA4 in a mouse model of Parkinson's disease. Bba-Mol. Basis Dis. 1868, 166365 (2022).","journal-title":"Bba-Mol. Basis Dis."},{"key":"8854_CR24","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/cdd.2015.158","volume":"23","author":"Y Xie","year":"2016","unstructured":"Xie, Y. et al. Ferroptosis: process and function. Cell Death Differ. 23, 369\u2013379 (2016).","journal-title":"Cell Death Differ."},{"key":"8854_CR25","doi-asserted-by":"publisher","first-page":"12005","DOI":"10.1074\/jbc.M113.530527","volume":"289","author":"RC Laker","year":"2014","unstructured":"Laker, R. C. et al. A novel MitoTimer reporter gene for mitochondrial content, structure, stress, and damage in vivo. J. Biol. Chem. 289, 12005\u201312015 (2014).","journal-title":"J. Biol. Chem."},{"key":"8854_CR26","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.nbd.2016.05.011","volume":"94","author":"B Do Van","year":"2016","unstructured":"Do Van, B. et al. Ferroptosis, a newly characterized form of cell death in Parkinson's disease that is regulated by PKC. Neurobiol. Dis. 94, 169\u2013178 (2016).","journal-title":"Neurobiol. Dis."},{"key":"8854_CR27","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell, B. R. et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell 171, 273\u2013285 (2017).","journal-title":"Cell"},{"key":"8854_CR28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13024-017-0149-0","volume":"12","author":"H Xicoy","year":"2017","unstructured":"Xicoy, H., Wieringa, B. & Martens, G. J. The SH-SY5Y cell line in Parkinson's disease research: a systematic review. Mol. Neurodegener. 12, 10 (2017).","journal-title":"Mol. Neurodegener."},{"key":"8854_CR29","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1126\/science.aag2590","volume":"353","author":"RM Ransohoff","year":"2016","unstructured":"Ransohoff, R. M. How neuroinflammation contributes to neurodegeneration. Science 353, 777\u2013783 (2016).","journal-title":"Science"},{"key":"8854_CR30","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.freeradbiomed.2018.06.037","volume":"133","author":"H Kawabata","year":"2019","unstructured":"Kawabata, H. Transferrin and transferrin receptors update. Free Radic. Biol. Med. 133, 46\u201354 (2019).","journal-title":"Free Radic. Biol. Med."},{"key":"8854_CR31","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/nrn983","volume":"3","author":"J Lotharius","year":"2002","unstructured":"Lotharius, J. & Brundin, P. Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein. Nat. Rev. Neurosci. 3, 932\u2013942 (2002).","journal-title":"Nat. Rev. Neurosci."},{"key":"8854_CR32","doi-asserted-by":"publisher","first-page":"105760","DOI":"10.1016\/j.neuint.2024.105760","volume":"177","author":"S Negi","year":"2024","unstructured":"Negi, S., Khurana, N. & Duggal, N. The misfolding mystery: \u03b1-synuclein and the pathogenesis of Parkinson's disease. Neurochem Int. 177, 105760 (2024).","journal-title":"Neurochem Int."},{"key":"8854_CR33","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.molmed.2022.02.003","volume":"28","author":"ZL Wang","year":"2022","unstructured":"Wang, Z. L., Yuan, L., Li, W. & Li, J. Y. Ferroptosis in Parkinson's disease: glia-neuron crosstalk. Trends Mol. Med. 28, 258\u2013269 (2022).","journal-title":"Trends Mol. Med."},{"key":"8854_CR34","doi-asserted-by":"publisher","first-page":"1359453","DOI":"10.3389\/fncel.2024.1359453","volume":"18","author":"LJ Wang","year":"2024","unstructured":"Wang, L. J. et al. Research progress on ferroptosis in the pathogenesis and treatment of neurodegenerative diseases. Front. Cell Neurosci. 18, 1359453 (2024).","journal-title":"Front. Cell Neurosci."},{"key":"8854_CR35","doi-asserted-by":"publisher","first-page":"101896","DOI":"10.1016\/j.redox.2021.101896","volume":"41","author":"L Ma","year":"2021","unstructured":"Ma, L. et al. Parkinson's disease: alterations in iron and redox biology as a key to unlock therapeutic strategies. Redox Biol. 41, 101896 (2021).","journal-title":"Redox Biol."},{"key":"8854_CR36","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/MCO.0b013e32831ba07c","volume":"12","author":"JM Stankiewicz","year":"2009","unstructured":"Stankiewicz, J. M. & Brass, S. D. Role of iron in neurotoxicity: a cause for concern in the elderly? Curr. Opin. Clin. Nutr. 12, 22\u201329 (2009).","journal-title":"Curr. Opin. Clin. Nutr."},{"key":"8854_CR37","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/jnc.16040","volume":"168","author":"A Carmona","year":"2024","unstructured":"Carmona, A. et al. Metal dyshomeostasis in the substantia nigra of patients with Parkinson's disease or multiple sclerosis. J. Neurochem. 168, 128\u2013141 (2024).","journal-title":"J. Neurochem."},{"key":"8854_CR38","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1093\/brain\/123.12.2423","volume":"123","author":"JM Graham","year":"2000","unstructured":"Graham, J. M., Paley, M. N., Grunewald, R. A., Hoggard, N. & Griffiths, P. D. Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence. Brain 123, 2423\u20132431 (2000).","journal-title":"Brain"},{"key":"8854_CR39","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00702-022-02505-5","volume":"129","author":"PB Foley","year":"2022","unstructured":"Foley, P. B., Hare, D. J. & Double, K. L. A brief history of brain iron accumulation in Parkinson disease and related disorders. J. Neural Transm. 129, 505\u2013520 (2022).","journal-title":"J. Neural Transm."},{"key":"8854_CR40","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41531-021-00199-2","volume":"7","author":"F Depierreux","year":"2021","unstructured":"Depierreux, F. et al. Parkinson's disease multimodal imaging: F-DOPA PET, neuromelanin-sensitive and quantitative iron-sensitive MRI. npj Parkinson's Dis. 7, 57 (2021).","journal-title":"npj Parkinson's Dis."},{"key":"8854_CR41","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1093\/brain\/awab191","volume":"144","author":"E Biondetti","year":"2021","unstructured":"Biondetti, E. et al. The spatiotemporal changes in dopamine neuromelanin and iron characterizing Parkinson's disease. Brain 144, 3114\u20133125 (2021).","journal-title":"Brain"},{"key":"8854_CR42","doi-asserted-by":"publisher","first-page":"4628","DOI":"10.1007\/s12035-020-02049-3","volume":"57","author":"YR Sun","year":"2020","unstructured":"Sun, Y. R. et al. Activation of p62-Keap1-Nrf2 pathway protects 6-hydroxydopamine-induced ferroptosis in dopaminergic cells. Mol. Neurobiol. 57, 4628\u20134641 (2020).","journal-title":"Mol. Neurobiol."},{"key":"8854_CR43","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/cddiscovery.2017.13","volume":"3","author":"K Ito","year":"2017","unstructured":"Ito, K. et al. MPP plus induces necrostatin-1-and ferrostatin-1-sensitive necrotic death of neuronal SH-SY5Y cells. Cell Death Discov. 3, 17013 (2017).","journal-title":"Cell Death Discov."},{"key":"8854_CR44","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41401-023-01153-z","volume":"45","author":"QQ Shen","year":"2024","unstructured":"Shen, Q. Q. et al. Cell senescence induced by toxic interaction between alpha-synuclein and iron precedes nigral dopaminergic neuron loss in a mouse model of Parkinson's disease. Acta Pharm. Sin. 45, 268\u2013281 (2024).","journal-title":"Acta Pharm. Sin."},{"key":"8854_CR45","doi-asserted-by":"publisher","first-page":"e2300325","DOI":"10.1002\/advs.202300325","volume":"10","author":"YM Wang","year":"2023","unstructured":"Wang, Y. M., Wu, S., Li, Q., Sun, H. Y. & Wang, H. Q. Pharmacological inhibition of ferroptosis as a therapeutic target for neurodegenerative diseases and strokes. Adv. Sci. 10, e2300325 (2023).","journal-title":"Adv. Sci."},{"key":"8854_CR46","doi-asserted-by":"publisher","first-page":"103165","DOI":"10.1016\/j.redox.2024.103165","volume":"73","author":"N Renner","year":"2024","unstructured":"Renner, N. et al. Modeling ferroptosis in human dopaminergic neurons: Pitfalls and opportunities for neurodegeneration research. Redox Biol. 73, 103165 (2024).","journal-title":"Redox Biol."},{"key":"8854_CR47","first-page":"2706783","volume":"2019","author":"AB Enogieru","year":"2019","unstructured":"Enogieru, A. B., Omoruyi, S. I., Hiss, D. C. & Ekpo, O. E. GRP78\/BIP\/HSPA5 as a therapeutic target in models of Parkinson's disease: a mini review. Adv. Pharm. Sci. 2019, 2706783 (2019).","journal-title":"Adv. Pharm. Sci."},{"key":"8854_CR48","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.freeradbiomed.2023.08.021","volume":"208","author":"NN Ai","year":"2023","unstructured":"Ai, N. N. et al. Azoramide prevents MPP plus -induced dopaminergic neuronal death via upregulating ER chaperone BiP expression. Free Radic. Bio Med. 208, 299\u2013308 (2023).","journal-title":"Free Radic. Bio Med"},{"key":"8854_CR49","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1080\/1028415X.2019.1613764","volume":"24","author":"A Shah","year":"2021","unstructured":"Shah, A., Chao, J., Legido-Quigley, C. & Chang, R. C. Oxyresveratrol exerts ATF4- and Grp78-mediated neuroprotection against endoplasmic reticulum stress in experimental Parkinson's disease. Nutr. Neurosci. 24, 181\u2013196 (2021).","journal-title":"Nutr. Neurosci."},{"key":"8854_CR50","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1038\/mt.2012.28","volume":"20","author":"MS Gorbatyuk","year":"2012","unstructured":"Gorbatyuk, M. S. et al. Glucose regulated protein 78 diminishes \u03b1-synuclein neurotoxicity in a rat model of Parkinson disease. Mol. Ther. 20, 1327\u20131337 (2012).","journal-title":"Mol. Ther."},{"key":"8854_CR51","first-page":"35","volume":"35","author":"P Ponka","year":"1998","unstructured":"Ponka, P., Beaumont, C. & Richardson, D. R. Function and regulation of transferrin and ferritin. Semin Hematol. 35, 35\u201354 (1998).","journal-title":"Semin Hematol."},{"key":"8854_CR52","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1046\/j.1432-1327.2000.01079.x","volume":"267","author":"DR Richardson","year":"2000","unstructured":"Richardson, D. R. The role of the membrane-bound tumour antigen, melanotransferrin (p97), in iron uptake by the human malignant melanoma cell. Eur. J. Biochem. 267, 1290\u20131298 (2000).","journal-title":"Eur. J. Biochem."},{"key":"8854_CR53","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41586-018-0372-z","volume":"560","author":"ZY Zhong","year":"2018","unstructured":"Zhong, Z. Y. et al. New mitochondrial DNA synthesis enables NLRP3 inflammasome activation. Nature 560, 198\u2013203 (2018).","journal-title":"Nature"},{"key":"8854_CR54","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40880-018-0288-x","volume":"38","author":"P Koppula","year":"2018","unstructured":"Koppula, P., Zhang, Y., Zhuang, L. & Gan, B. Amino acid transporter SLC7A11\/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer. Cancer Commun. 38, 12 (2018).","journal-title":"Cancer Commun."},{"key":"8854_CR55","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.freeradbiomed.2025.02.040","volume":"231","author":"Y Ye","year":"2025","unstructured":"Ye, Y. et al. Nrf2 alleviates acute ischemic stroke induced ferroptosis via regulating xCT\/GPX4 pathway. Free Radic. Biol. Med. 231, 153\u2013162 (2025).","journal-title":"Free Radic. Biol. Med."},{"key":"8854_CR56","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.4103\/1673-5374.274344","volume":"15","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. et al. Neuroprotective effect of deferoxamine on erastin-induced ferroptosis in primary cortical neurons. Neural Regen. Res. 15, 1539\u20131545 (2020).","journal-title":"Neural Regen. Res."},{"key":"8854_CR57","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1038\/s42003-024-07377-x","volume":"7","author":"Y Ma","year":"2024","unstructured":"Ma, Y. et al. Chemerin attenuates acute kidney injury by inhibiting ferroptosis via the AMPK\/NRF2\/SLC7A11 axis. Commun. Biol. 7, 1679 (2024).","journal-title":"Commun. Biol."},{"key":"8854_CR58","doi-asserted-by":"publisher","first-page":"103029","DOI":"10.1016\/j.redox.2024.103029","volume":"69","author":"Y Fu","year":"2024","unstructured":"Fu, Y. et al. Salvianolic acid B attenuates liver fibrosis by targeting Ecm1 and inhibiting hepatocyte ferroptosis. Redox Biol. 69, 103029 (2024).","journal-title":"Redox Biol."},{"key":"8854_CR59","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon, S. J. et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149, 1060\u20131072 (2012).","journal-title":"Cell"},{"key":"8854_CR60","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.cell.2009.02.013","volume":"136","author":"F Soldner","year":"2009","unstructured":"Soldner, F. et al. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 136, 964\u2013977 (2009).","journal-title":"Cell"},{"key":"8854_CR61","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.stem.2023.05.015","volume":"30","author":"MS Kim","year":"2023","unstructured":"Kim, M. S. et al. Advanced human iPSC-based preclinical model for Parkinson's disease with optogenetic alpha-synuclein aggregation. Cell Stem Cell 30, 973\u2013986 (2023).","journal-title":"Cell Stem Cell"},{"key":"8854_CR62","doi-asserted-by":"publisher","first-page":"176819","DOI":"10.1016\/j.ejphar.2024.176819","volume":"980","author":"R Lal","year":"2024","unstructured":"Lal, R., Singh, A., Watts, S. & Chopra, K. Experimental models of Parkinson's disease: challenges and opportunities. Eur. J. Pharm. 980, 176819 (2024).","journal-title":"Eur. J. Pharm."},{"key":"8854_CR63","doi-asserted-by":"publisher","first-page":"102302","DOI":"10.1016\/j.isci.2021.102302","volume":"24","author":"B Li","year":"2021","unstructured":"Li, B. et al. Acetylation of NDUFV1 induced by a newly synthesized HDAC6 inhibitor HGC rescues dopaminergic neuron loss in Parkinson models. iScience 24, 102302 (2021).","journal-title":"iScience"},{"key":"8854_CR64","doi-asserted-by":"publisher","first-page":"106133","DOI":"10.1016\/j.phrs.2022.106133","volume":"177","author":"YJ Wang","year":"2022","unstructured":"Wang, Y. J. et al. CD44 deficiency represses neuroinflammation and rescues dopaminergic neurons in a mouse model of Parkinson's disease. Pharm. Res. 177, 106133 (2022).","journal-title":"Pharm. Res."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08854-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08854-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08854-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:03:41Z","timestamp":1760029421000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08854-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8854"],"URL":"https:\/\/doi.org\/10.1038\/s42003-025-08854-7","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]},"assertion":[{"value":"6 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1453"}}